Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study.

C L Deckers1, Y A Hekster, A Keyser

  • 1Institute of Neurology, University Medical Center Nijmegen, Nijmegen, the Netherlands. clp.deckers@planet.nl

Epilepsia
|March 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing owner reported and genetic breed identification reveals high concordance in a large cohort from the Dog Aging Project.

Scientific reports·2025
Same author

[Anesthesia management in implantation of baroreceptor stimulators].

Der Anaesthesist·2015
Same author

The outcome of epilepsy and its measurement.

Epilepsia·2012
Same author

The organization and utilization of a case register on epilepsy.

International journal of adolescent medicine and health·2012
Same author

Narcolepsy and psychiatry: an evolving association of increasing interest.

Sleep medicine·2011
Same author

Anthropological neurology: symptoms and their meanings according to Joseph Prick (1909-1978).

Journal of the history of the neurosciences·2011
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
Same journal

Outcome trajectories after pediatric epilepsy surgery vary by biopsychosocial phenotypes.

Epilepsia·2026
Same journal

Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.

Epilepsia·2026
Same journal

Long-term mortality after status epilepticus: A 5-year analysis study.

Epilepsia·2026
Same journal

The Epilepsy-Cog study: Methods to establish a harmonized study of late onset epilepsy in a metacohort of six population-based cohorts in the United States.

Epilepsia·2026
Same journal

Systematic review and meta-analysis of lifestyle modification interventions and their impact on seizure reduction and quality of life.

Epilepsia·2026
See all related articles

This study found no significant differences in overall neurotoxicity between epilepsy monotherapy and polytherapy. Both treatment approaches demonstrated comparable efficacy in reducing seizure frequency and overall systemic toxicity.

Area of Science:

  • Neurology
  • Clinical Pharmacology
  • Epilepsy Treatment

Background:

  • Monotherapy is the established standard for epilepsy treatment due to concerns about polytherapy toxicity.
  • Previous comparisons between monotherapy and polytherapy lacked robust double-blind designs and equivalent drug dosages.

Purpose of the Study:

  • To conduct a double-blind clinical trial comparing carbamazepine (CBZ) monotherapy with a combination of CBZ and valproate (VPA) polytherapy.
  • To evaluate neurotoxicity as the primary outcome measure in epilepsy treatment.

Main Methods:

  • 130 adult patients with untreated seizures were randomized to receive either CBZ monotherapy or CBZ + VPA polytherapy at equal drug loads.
  • Outcomes assessed included seizure counts, epilepsy scales, and neuropsychological tests at multiple time points.

Related Experiment Videos

Main Results:

  • No statistically significant differences were observed in seizure reduction, overall neurotoxicity, or systemic toxicity between monotherapy and polytherapy groups.
  • Adverse effects varied, with more sedation in monotherapy and weight gain in polytherapy; however, fewer patients withdrew from polytherapy due to adverse effects.

Conclusions:

  • This double-blind trial indicates no significant difference in overall neurotoxicity between carbamazepine monotherapy and a combination of carbamazepine and valproate polytherapy.
  • Both treatment strategies showed comparable efficacy and safety profiles in the studied patient population.